🔍
Search Results - muscular+disorders
4
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Human IPSC-Based Drug Testing Platform for Duchenne Muscular Dystrophy
Unmet NeedThe development of new drugs is a capital and time intensive process. For this reason, the development of orphan drugs for those diseases that affect a small subset of the population. One of such diseases, Duchenne’s muscular dystrophy (DMD) affects 1 in 5000 boys worldwide and has no known cure. Current drug screen platforms include animal...
Published: 3/14/2025
|
Inventor(s):
Gabsang Lee
,
Kathryn Wagner
,
Congshan (Sunny) Sun
Keywords(s):
Discovery/Research Tools
,
Disease Indication
,
In Vitro Research Tool
,
Muscular Disorders
,
Small Molecules
,
Therapeutic Matter
,
Therapeutic Substance
,
Therapeutics
Category(s):
Clinical and Disease Specializations > Rare Diseases
,
Technology Classifications > Therapeutic Modalities > Small Molecules
,
Technology Classifications > Research Tools > Research Stem Cells
Soluble Form of Activin Type IIB Receptor (ACVR2B/Fc)
Invention Novelty: This technology identifies the use of soluble receptor (ACVR2B/Fc) to block the activities of members of the TGF-beta superfamily of signaling molecules.Value Proposition:Myostatin is a member of the TGF-β family; it suppresses muscle growth and its absence stimulates muscle growth substantially. Most of the myostatin inhibitors...
Published: 3/13/2025
|
Inventor(s):
Se-Jin Lee
Keywords(s):
Biologics
,
Disease Indication
,
Muscular Disorders
,
Protein
,
Therapeutic Matter
,
Therapeutic Substance
,
Therapeutics
Category(s):
Clinical and Disease Specializations
,
Clinical and Disease Specializations > Musculoskeletal
,
Technology Classifications > Therapeutic Modalities > Biologics
,
Technology Classifications > Therapeutic Modalities > Proteins
,
Technology Classifications > Therapeutic Modalities
Rabbit Serum 5690
C10529: Rabbit Serum 5690: Antibodies Against Rat Lmo7Value Proposition: • Polyclonal antibodies against rat Lmo7Technical Details: Nuclear lamina is a dense fibrillar network inside the nucleus of eukaryotic cells composed of intermediate filaments (lamins) and membrane associated proteins called lamin-associated membrane proteins. The nuclear lamina...
Published: 3/13/2025
|
Inventor(s):
Katherine Wilson
Keywords(s):
Antibodies
,
Basic Research Biomarker
,
Discovery/Research Tools
,
Disease Indication
,
Genetic Disorders
,
Muscular Disorders
,
Peptides
,
Polyclonal Antibodies
,
Proteomics/Immunoassays
,
Proteomics/Immunoassays Antiserum
,
Recombinant Proteins
,
Research Reagent
Category(s):
Technology Classifications > Research Tools > Antibodies
,
Technology Classifications > Research Tools > Assays
,
Technology Classifications > Research Tools
,
Technology Classifications > Research Tools > Proteins, Ligands & Receptors
,
Clinical and Disease Specializations > Genetic Diseases
,
Clinical and Disease Specializations > Rare Diseases
,
Clinical and Disease Specializations > Musculoskeletal
C05182: Novel Protein Increases Muscle Mass
Technical Details: Muscle mass is normally regulated by the activities of members of the transforming growth factor-B (TGF-B) superfamily, which act to limit muscle growth. Scientists at JHU have now found a protein that is capable of binding certain members of the TGF-B family and inhibiting their activities in vitro. Therefore this protein has important...
Published: 3/13/2025
|
Inventor(s):
Se-Jin Lee
Keywords(s):
Biologics
,
Disease Indication
,
Muscular Disorders
,
Protein
,
Single
,
Targeted Therapy
,
Therapeutic Matter
,
Therapeutic Substance
,
Therapeutics
,
Therapy Type
Category(s):
Clinical and Disease Specializations
,
Clinical and Disease Specializations > Musculoskeletal
,
Technology Classifications > Therapeutic Modalities > Biologics
,
Technology Classifications > Therapeutic Modalities > Proteins
,
Technology Classifications > Therapeutic Modalities > Targets
,
Technology Classifications > Therapeutic Modalities
JHTV Home
|
Search
|
Login/Subscribe
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by
Inteum